ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Van Herk Investments B.V.(10.1%),Van Herk Investments THI B.V.(10.1%)等
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Van Herk Investments B.V.(8.8%),Van Herk Investments THI B.V.(8.8%)等
ProQR Therapeutics | SC 13G:超過5%持股股東披露文件-Van Herk Investments B.V.(5.3%),Van Herk Investments THI B.V.(5.3%)等
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RTW Investments, LP(0%),Roderick Wong(0%)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Patrick Johan Hendrik Krol(7.6%),Privium Fund Management B.V.(7.5%)等
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(0.000%),Abigail P. Johnson(0.000%)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Adage Capital Partners, L.P.(4.49%),Adage Capital Partners GP, L.L.C.(4.49%)等
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-GOLDMAN SACHS & CO. LLC(0.0 %),THE GOLDMAN SACHS GROUP, INC.(0.0 %)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Eli Lilly and Company(16.6%)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Wellington Management Group LLP(0.00%),Wellington Group Holdings LLP(0.00%)等
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RTW Investments, LP(9.9%),Roderick Wong(9.9%)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Adage Capital Partners, L.P.(6.63%),Adage Capital Partners GP, L.L.C.(6.63%)等
ProQR Therapeutics | SC 13G:超過5%持股股東披露文件-FMR LLC(6.271%),Abigail P. Johnson(6.271%)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(5.6 %),GOLDMAN SACHS & CO. LLC(5.6 %)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Patrick Johan Hendrik Krol(6.8%),Stichting Aescap Life Sciences(6.7%)等
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Wellington Management Group LLP(5.65%),Wellington Group Holdings LLP(5.65%)等
ProQR Therapeutics | SC 13G:超過5%持股股東披露文件
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)
ProQR Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)